Cargando…

Long‐term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand

AIMS: Contemporary long‐term survival following a heart failure (HF) hospitalization is uncertain. We evaluated survival up to 10 years after a HF hospitalization using national data from Australia and New Zealand, identified predictors of survival, and estimated the attributable loss in life expect...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariharaputhiran, Saranya, Peng, Yang, Ngo, Linh, Ali, Anna, Hossain, Sadia, Visvanathan, Renuka, Adams, Robert, Chan, Wandy, Ranasinghe, Isuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804480/
https://www.ncbi.nlm.nih.gov/pubmed/35748124
http://dx.doi.org/10.1002/ejhf.2595
_version_ 1784862119536099328
author Hariharaputhiran, Saranya
Peng, Yang
Ngo, Linh
Ali, Anna
Hossain, Sadia
Visvanathan, Renuka
Adams, Robert
Chan, Wandy
Ranasinghe, Isuru
author_facet Hariharaputhiran, Saranya
Peng, Yang
Ngo, Linh
Ali, Anna
Hossain, Sadia
Visvanathan, Renuka
Adams, Robert
Chan, Wandy
Ranasinghe, Isuru
author_sort Hariharaputhiran, Saranya
collection PubMed
description AIMS: Contemporary long‐term survival following a heart failure (HF) hospitalization is uncertain. We evaluated survival up to 10 years after a HF hospitalization using national data from Australia and New Zealand, identified predictors of survival, and estimated the attributable loss in life expectancy. METHODS AND RESULTS: Patients hospitalized with a primary diagnosis of HF from 2008–2017 were identified and all‐cause mortality assessed by linking with Death Registries. Flexible parametric survival models were used to estimate survival, predictors of survival and loss in life expectancy. A total of 283 048 patients with HF were included (mean age 78.2 ± 12.3 years, 50.8% male). Of these, 48.3% (48.1–48.5) were surviving by 3 years, 34.1% (33.9–34.3) by 5 years and 17.1% (16.8–17.4) by 10 years (median survival 2.8 years). Survival declined with age with 53.4% of patients aged 18–54 years and 6.2% aged ≥85 years alive by 10 years (adjusted hazard ratio [aHR] for mortality 4.84, 95% confidence interval [CI] 4.65–5.04 for ≥85 years vs. 18–54 years) and was worse in male patients (aHR 1.14, 95% CI 1.13–1.15). Prior HF (aHR 1.20, 95% CI 1.18–1.22), valvular and rheumatic heart disease (aHR 1.11, 95% CI 1.10–1.13) and vascular disease (aHR 1.07, 95% CI 1.04–1.09) were cardiovascular comorbidities most strongly associated with long‐term death. Non‐cardiovascular comorbidities and geriatric syndromes were common and associated with higher mortality. Compared with the general population, HF was associated with a loss of 7.3 years in life expectancy (or 56.6% of the expected life expectancy) and reached 20.5 years for those aged 18–54 years. CONCLUSION: Less than one in five patients hospitalized for HF were surviving by 10 years with patients experiencing almost 60% loss in life expectancy compared with the general population, highlighting the considerable persisting societal burden of HF. Concerted multidisciplinary efforts are needed to improve post‐hospitalization outcomes of HF.
format Online
Article
Text
id pubmed-9804480
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Ltd.
record_format MEDLINE/PubMed
spelling pubmed-98044802023-01-03 Long‐term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand Hariharaputhiran, Saranya Peng, Yang Ngo, Linh Ali, Anna Hossain, Sadia Visvanathan, Renuka Adams, Robert Chan, Wandy Ranasinghe, Isuru Eur J Heart Fail Research Articles AIMS: Contemporary long‐term survival following a heart failure (HF) hospitalization is uncertain. We evaluated survival up to 10 years after a HF hospitalization using national data from Australia and New Zealand, identified predictors of survival, and estimated the attributable loss in life expectancy. METHODS AND RESULTS: Patients hospitalized with a primary diagnosis of HF from 2008–2017 were identified and all‐cause mortality assessed by linking with Death Registries. Flexible parametric survival models were used to estimate survival, predictors of survival and loss in life expectancy. A total of 283 048 patients with HF were included (mean age 78.2 ± 12.3 years, 50.8% male). Of these, 48.3% (48.1–48.5) were surviving by 3 years, 34.1% (33.9–34.3) by 5 years and 17.1% (16.8–17.4) by 10 years (median survival 2.8 years). Survival declined with age with 53.4% of patients aged 18–54 years and 6.2% aged ≥85 years alive by 10 years (adjusted hazard ratio [aHR] for mortality 4.84, 95% confidence interval [CI] 4.65–5.04 for ≥85 years vs. 18–54 years) and was worse in male patients (aHR 1.14, 95% CI 1.13–1.15). Prior HF (aHR 1.20, 95% CI 1.18–1.22), valvular and rheumatic heart disease (aHR 1.11, 95% CI 1.10–1.13) and vascular disease (aHR 1.07, 95% CI 1.04–1.09) were cardiovascular comorbidities most strongly associated with long‐term death. Non‐cardiovascular comorbidities and geriatric syndromes were common and associated with higher mortality. Compared with the general population, HF was associated with a loss of 7.3 years in life expectancy (or 56.6% of the expected life expectancy) and reached 20.5 years for those aged 18–54 years. CONCLUSION: Less than one in five patients hospitalized for HF were surviving by 10 years with patients experiencing almost 60% loss in life expectancy compared with the general population, highlighting the considerable persisting societal burden of HF. Concerted multidisciplinary efforts are needed to improve post‐hospitalization outcomes of HF. John Wiley & Sons, Ltd. 2022-08-02 2022-09 /pmc/articles/PMC9804480/ /pubmed/35748124 http://dx.doi.org/10.1002/ejhf.2595 Text en © 2022 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Hariharaputhiran, Saranya
Peng, Yang
Ngo, Linh
Ali, Anna
Hossain, Sadia
Visvanathan, Renuka
Adams, Robert
Chan, Wandy
Ranasinghe, Isuru
Long‐term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand
title Long‐term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand
title_full Long‐term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand
title_fullStr Long‐term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand
title_full_unstemmed Long‐term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand
title_short Long‐term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand
title_sort long‐term survival and life expectancy following an acute heart failure hospitalization in australia and new zealand
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804480/
https://www.ncbi.nlm.nih.gov/pubmed/35748124
http://dx.doi.org/10.1002/ejhf.2595
work_keys_str_mv AT hariharaputhiransaranya longtermsurvivalandlifeexpectancyfollowinganacuteheartfailurehospitalizationinaustraliaandnewzealand
AT pengyang longtermsurvivalandlifeexpectancyfollowinganacuteheartfailurehospitalizationinaustraliaandnewzealand
AT ngolinh longtermsurvivalandlifeexpectancyfollowinganacuteheartfailurehospitalizationinaustraliaandnewzealand
AT alianna longtermsurvivalandlifeexpectancyfollowinganacuteheartfailurehospitalizationinaustraliaandnewzealand
AT hossainsadia longtermsurvivalandlifeexpectancyfollowinganacuteheartfailurehospitalizationinaustraliaandnewzealand
AT visvanathanrenuka longtermsurvivalandlifeexpectancyfollowinganacuteheartfailurehospitalizationinaustraliaandnewzealand
AT adamsrobert longtermsurvivalandlifeexpectancyfollowinganacuteheartfailurehospitalizationinaustraliaandnewzealand
AT chanwandy longtermsurvivalandlifeexpectancyfollowinganacuteheartfailurehospitalizationinaustraliaandnewzealand
AT ranasingheisuru longtermsurvivalandlifeexpectancyfollowinganacuteheartfailurehospitalizationinaustraliaandnewzealand